Status:
UNKNOWN
DEMAND - Multifactorial Study to Reduce Dementia in People With Type 2 Diabetes
Lead Sponsor:
Umeå University
Conditions:
Type 2 Diabetes Mellitus
Mild Cognitive Impairment
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
In the DEMAND pilot study, we will recruit and randomize 80 participants at two study sites (Umeå and Uppsala) for a one-year intervention. The primary objectives are to study the inclusion rate, the ...
Detailed Description
To be inserted.
Eligibility Criteria
Inclusion
- type 2 diabetes diagnosed in the last year
- age \>=65 years
- signed consent form
- Mild cognitive impairment
Exclusion
- diagnosis type 1 diabetes
- major neurocognitive degeneration
- serious illness with live expectancy less than 3 years
- drug- or alcohol-abuse or other neurological / psychiatric illness which affects the outcome
- depressive syndrome
- predicted inability to conduct the study because of drug abuse, serious illness, language issues
- documented episodes of hypoglycemia where help of a third part was needed
- Allergy to fish or nuts
- Angina pectoris
- Heart failure (NYHA 3-4)
Key Trial Info
Start Date :
October 19 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2023
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03877783
Start Date
October 19 2020
End Date
June 30 2023
Last Update
March 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Umeå University
Umeå, Västerbotten County, Sweden, 90185